{"nct_id":"NCT04762511","title":"A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years","status":"TERMINATED","status_verified_date":"2021-06","start_date":"2021-03-02","start_date_type":"ACTUAL","primary_completion_date":"2021-05-26","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}